Gene therapy for osteoporosis: evaluation in a murine ovariectomy model
- 1 December 2001
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (23), 1770-1776
- https://doi.org/10.1038/sj.gt.3301594
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 40 references indexed in Scilit:
- Gene Therapy in OrthopaedicsOrthopaedic Nursing, 2000
- Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passagingGene Therapy, 1999
- Adenoviral transduction of human osteoblastic cell cultures: A new perspective for gene therapy of bone diseasesActa Orthopaedica, 1999
- Regional gene therapy with a BMP‐2‐producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodentsJournal of Orthopaedic Research, 1998
- Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.JCI Insight, 1994
- Biologically meaningful determinants of the in vitro strength of lumbar vertebraeBone, 1991
- Mesenchymal stem cellsJournal of Orthopaedic Research, 1991
- Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal womenJournal of Bone and Mineral Research, 1990
- Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitroJournal of Bone and Mineral Research, 1989
- An interleukin 1 like factor stimulates bone resorption in vitroNature, 1983